US stocks rose, driving the Standard & Poor's 500 Index to its biggest weekly gain since September, after new reports showed growing confidence among consumers and higher demand for semiconductor equipment.
General Electric Co, whose interests include broadcasting, plastics, airplane engines, and home mortgages, led the advance.
"People sense there's a recovery out there not too far down the road," said Joe DeMarco, head of trading at HSBC Asset Management Americas Inc, which oversees about US$12 billion.
The S&P 500 rose 8.36, or 0.8 percent, to 1,106.59. Drug stocks, including Pfizer Inc, accounted for 40 percent of the gain. The Dow Jones Industrial Average added 63.87, or 0.6 percent, to 10,353.08. The NASDAQ Composite Index climbed 10.95, or 0.6 percent, to 1,741.39, closing its best week in 13 months.
For the week, the S&P 500 rose 4.9 percent, the most since the week ended Sept. 28. The Dow gained 4.2 percent. The NASDAQ climbed 8.8 percent. Stocks gained for the first week in four.
Indexes got a boost from an unexpected rise in the University of Michigan's consumer confidence poll. Investors said the survey's rise to a 1 1/2-year high fit with other signs this week pointing to a quickening recovery. They cited better-than-expected retail sales and data showing the chip industry is rebounding.
Wal-Mart Stores Inc, Dell Computer Corp and Applied Materials Inc. also reported better-than-expected profits or sales this week.
About six stocks rose for every five that fell on the New York Stock Exchange and the NASDAQ Stock Market. Some 1.25 billion shares traded on the Big Board, 4 percent below the three-month daily average.
General Electric added the most to the S&P 500, gaining US$1.45 to US$33.45 and capping a 9.1 percent gain this week. Chief Executive Jeffrey Immelt said this week that the plastics and broadcast businesses, the most sensitive to swings in the economy, are picking up.
Drug stocks were the day's best-performing S&P 500 group, rebounding from losses earlier this week. Schering-Plough Corp.
rose US$1.37 to US$26.12 after settling regulators' complaints over manufacturing deficiencies at plants in New Jersey and Puerto Rico. The drugmaker will pay a record US$500 million fine.
Abbott Laboratories rose US$1.85 to US$47.60, cutting its weekly loss to 7.1 percent. Pfizer gained US$1.27 to US$37.09, and Merck & Co jumped US$1.53 to US$58.13.
Intel Corp, the biggest maker of computer microprocessors, added US$0.43 to US$31.20, for a weekly advance of 16 percent. An industry group said orders for semiconductor manufacturing equipment exceeded shipments in April for a second month.
The so-called book-to-bill reinforced a report from Applied Materials earlier this week. The biggest maker of chip equipment said orders rose more than expected.
DaimlerChrysler AG gained US$1.71 to US$49.51. Chrysler, the US unit of the world's fifth largest carmaker, said it plans overtime at eight plants next week after a dealer survey showed US auto sales rose the first two weeks of this month.
Dell rose 10 cents to US$27.95, for a gain this week of 17 percent. The second-biggest maker of personal computers forecast second-quarter earnings of 18 cents a share on sales of US$8.2 billion, compared with analysts' estimate for profit of US$0.17 on revenue of US$8 billion.
"There have been enough positive earnings announcements to suggest the bottom has been put in," said Jerry Castellini, who manages US$1.2 billion as president of CastleArk Management in Chicago.
Wal-Mart rose 8.7 percent this week after reporting on Tuesday that profit in the quarter ended April 30 rose 20 percent, the most in two years. Kohl's Corp jumped US$4.20 to US$77.75, capping a 12 percent advance this week.
Phone stocks including Verizon Communications Inc were Friday's biggest losers. BellSouth Corp, which serves customers in nine southeastern US states, said it will fire as many as 5,000 employees to cut costs, resulting in a charge against earnings of US$250 million to US$350 million.
Even with declines Friday, the S&P 500's broadest index of phone companies gained 8.7 percent this week, the most since January 2001.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained